
    
      A Randomized, Controlled, Prospective Study design in which one eye (Group A) receives
      Dextenza and the second eye (Group B) receives prednisolone acetate 1% QID 1 week, TID 1
      week, BID 1 week, and QD 1week, following bilateral RLE surgery. All eyes will receive
      topical moxifloxacin QID for one week and topical Ilevro QD for 4 weeks. Moxifloxacin and
      Ilevero are used in post-op regardless of the research. Post-operative evaluations to be
      performed on Day 1, Day 7, and 1 Month.
    
  